Article

Oncologist Richard T. Silver on Receiving the MPN Hero Award

Richard Silver, an oncologist focused on rare blood diseases called myeloproliferative neoplasms was named an MPN Hero for Commitment to the Broader MPN Community for 2014.

Richard Silver, who was named an MPN Hero at this year's event, is an oncologist and professor of medicine and Director Emeritus of the Richard T. Silver, M.D. Myeloproliferative Neoplasm Center in New York City. He is an attending physician at New York Presbyterian Hospital and medical director of The Cancer Research and Treatment Fund, Inc. Silver was named an MPN Hero for Commitment to the Broader MPN Community.

Silver has written four books and more than 275 peer-reviewed articles, has been the principal investigator in multiple clinical trials, sponsored bi-annual patient-hematologist seminars, is the co-inventor of the BMB biopsy technique, and was instrumental in founding the MPN Center for Research and Therapy. In recognition of his work, patients and colleagues established The Richard T. Silver Distinguished Professor of Hematology/Oncology Chair and Visiting Professorship in the Department of Medicine.

You can learn more about the MPN Heroes at curetoday.com/events/mpn.

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Image of doctor.
Image of man with black hair.
Picture of Dr. Pouneh Razavi
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Image of Crispino
Image of Dr. Reznick
Picture of Joy Anderson
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Anne M. Reb is a nurse practitioner with City of Hope.
Related Content